Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease, or developmental deficiency. Bone grafts and regenerative materials regenerate the natural bone and dental tissue.

The dental bone graft substitutes & regenerative materials pipeline market research report provides comprehensive information about the dental bone graft substitutes & regenerative materials pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information about various pipeline products and their estimated approval dates.

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Segments

The key segments in the dental bone graft substitutes & regenerative materials pipeline products market are tissue regenerative materials, synthetic dental bone graft substitutes, dental bone graft substitutes & dental materials, regenerative materials, and dental bone grafts. Tissue regenerative materials has the highest number of pipeline products in the dental bone graft substitutes & regenerative materials pipeline products market.

Regenerative Materials: Regenerative materials are biomaterials that facilitate the regeneration of lost periodontal hard and soft tissues. Regenerative materials include tissue regenerative materials and growth factors.

Dental Bone Grafts: Dental bone graft is used to augment or fill a defect created by surgery, trauma, disease, and developmental deficiency. These products are available in the form of blocks, gels, pastes, particulates, putty, and strips.

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Segments, 2022 (%)

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Segments

For more segment insights into the dental bone graft substitutes & regenerative materials pipeline products market, download a free report sample

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, Europe, Japan, China, New Zealand, Taiwan, the UK, India, Australia, and Canada. The US is the leading territory in the dental bone graft substitutes & regenerative materials pipeline products market.

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Territories, 2022 (%)

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Territories

For more territory insights into the dental bone graft substitutes & regenerative materials pipeline products market, download a free report sample

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Segmentation by Regulatory Paths

The dental bone graft substitutes & regenerative materials pipeline report provides detailed insights into the pipeline products by a regulatory path including 510(k), CE, Ninsho, NMPA, PMA, TGA, UKCA, ICAC, MDL, and BOPA. Most of the products follow the 510(k) pathway to enter the market.

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Regulatory Paths, 2022 (%)

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Analysis by Regulatory Paths

For more regulatory path insights into the dental bone graft substitutes & regenerative materials pipeline products market, download a free report sample

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market - Competitive Landscape

Some of the leading companies in the dental bone graft substitutes & regenerative materials pipeline products market are 3-D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Cayman Chemical Co, CellSeed Inc, Colorado Therapeutics, LLC, Fujifilm Corp, Histocell SL, Indian Institute of Technology Bombay, Induce Biologics Inc., and Ivory Graft Ltd.

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Report Overview

Key Territories The US, Europe, Japan, China, New Zealand, Taiwan, the UK, India, Australia, and Canada
Key Regulatory Paths 510(k), CE, Ninsho, NMPA, PMA, TGA, UKCA, ICAC, MDL, and BOPA
Key Segments Tissue Regenerative Materials, Synthetic Dental Bone Graft Substitutes, Dental Bone Graft Substitutes & Dental Materials, Regenerative Materials, and Dental Bone Grafts
Leading Companies 3-D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Cayman Chemical Co, CellSeed Inc, Colorado Therapeutics, LLC, Fujifilm Corp, Histocell SL, Indian Institute of Technology Bombay, Induce Biologics Inc., and Ivory Graft Ltd

Segments Covered in the Report

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Segments Outlook

  • Tissue Regenerative Materials
  • Synthetic Dental Bone Graft Substitutes
  • Dental Bone Graft Substitutes & Dental Materials
  • Regenerative Materials
  • Dental Bone Grafts

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Territories Outlook

  • The US
  • Europe
  • Japan
  • China
  • New Zealand
  • Taiwan
  • the UK
  • India
  • Australia
  • Canada

Dental Bone Graft Substitutes & Regenerative Materials Pipeline Products Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • Ninsho
  • NMPA
  • PMA
  • TGA
  • UKCA
  • ICAC
  • MDL
  • BOPA

Scope

  • Extensive coverage of the dental bone graft substitutes & regenerative materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of dental bone graft substitutes & regenerative materials and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to the approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of dental bone graft substitutes & regenerative materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3-D Matrix Ltd
Advanced Biotech Products Pvt Ltd
Cayman Chemical Co
CellSeed Inc
Colorado Therapeutics, LLC
credentis AG
curasan AG
Fujifilm Corp
Histocell SL
Indian Institute of Technology Bombay
Induce Biologics Inc.
Ivory Graft Ltd
Malla Reddy Institute of Medical Sciences
Maxigen Biotech Inc
Medtronic Plc
Nobel Biocare Services AG
Novatissue SAS
Orthocell Ltd
Orthogen LLC
Orthorebirth Co Ltd
Orthosera GmbH
PolyPid Ltd
Polytechnic University of Catalonia
RevBio Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Straumann Holding AG
SurgaColl Technologies Ltd
SweetBio, Inc.
Tetratherix Pty Ltd
Tigran Technologies AB
University of Bielefeld
University of Connecticut Health Center
University of Maryland
ZetaGen Therapeutics Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Dental Bone Graft Substitutes & Regenerative Materials Overview

  • 3 Products under Development

    • 3.1 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development
    • 3.2 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Segment
    • 3.3 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Territory
    • 3.4 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Regulatory Path
    • 3.5 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Estimated Approval Date
    • 3.6 Dental Bone Graft Substitutes & Regenerative Materials – Ongoing Clinical Trials

  • 4 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products under Development by Companies

    • 4.1 Dental Bone Graft Substitutes & Regenerative Materials Companies – Pipeline Products by Stage of Development
    • 4.2 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development

  • 5 Dental Bone Graft Substitutes & Regenerative Materials Companies and Product Overview

    • 5.1 3-D Matrix Ltd Company Overview

      • 5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Advanced Biotech Products Pvt Ltd Company Overview

      • 5.2.1 Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Cayman Chemical Co Company Overview

      • 5.3.1 Cayman Chemical Co Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 CellSeed Inc Company Overview

      • 5.4.1 CellSeed Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Colorado Therapeutics, LLC Company Overview

      • 5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 credentis AG Company Overview

      • 5.6.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 curasan AG Company Overview

      • 5.7.1 curasan AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Fujifilm Corp Company Overview

      • 5.8.1 Fujifilm Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Histocell SL Company Overview

      • 5.9.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Indian Institute of Technology Bombay Company Overview

      • 5.10.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Induce Biologics Inc. Company Overview

      • 5.11.1 Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Ivory Graft Ltd Company Overview

      • 5.12.1 Ivory Graft Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Malla Reddy Institute of Medical Sciences Company Overview

      • 5.13.1 Malla Reddy Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Maxigen Biotech Inc Company Overview

      • 5.14.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Medtronic Plc Company Overview

      • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Nobel Biocare Services AG Company Overview

      • 5.16.1 Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Novatissue SAS Company Overview

      • 5.17.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Orthocell Ltd Company Overview

      • 5.18.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Orthogen LLC Company Overview

      • 5.19.1 Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Orthorebirth Co Ltd Company Overview

      • 5.20.1 Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Orthosera GmbH Company Overview

      • 5.21.1 Orthosera GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 PolyPid Ltd Company Overview

      • 5.22.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Polytechnic University of Catalonia Company Overview

      • 5.23.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 RevBio Inc Company Overview

      • 5.24.1 RevBio Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Straumann Holding AG Company Overview

      • 5.26.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 SurgaColl Technologies Ltd Company Overview

      • 5.27.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 SweetBio, Inc. Company Overview

      • 5.28.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 Tetratherix Pty Ltd Company Overview

      • 5.29.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 Tigran Technologies AB Company Overview

      • 5.30.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 University of Bielefeld Company Overview

      • 5.31.1 University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 University of Connecticut Health Center Company Overview

      • 5.32.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.33 University of Maryland Company Overview

      • 5.33.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview

    • 5.34 ZetaGen Therapeutics Inc Company Overview

      • 5.34.1 ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Dental Bone Graft Substitutes & Regenerative Materials- Recent Developments

    • 6.1 Dec 01, 2022: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
    • 6.2 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.3 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.4 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.5 Nov 14, 2022: Dentsply Sirona Reports Third Quarter 2022 Results
    • 6.6 Oct 04, 2022: Exactech Names New Chief Financial Officer
    • 6.7 Sep 07, 2022: Medtronic to appear at September investor conferences
    • 6.8 Aug 25, 2022: Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
    • 6.9 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.10 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.11 Aug 17, 2022: Sven Weiler joins Endogena as VP Medicinal Chemistry
    • 6.12 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results
    • 6.13 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.14 Jun 16, 2022: MIchael Lai joins Endogena as Medical Director
    • 6.15 Jun 04, 2022: Moreno Menghini appointed Chief Medical Officer
    • 6.16 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.17 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
    • 6.18 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • 6.19 May 18, 2022: Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
    • 6.20 May 16, 2022: Zimmer Biomet Announces Appointment of New Chief Accounting Officer
    • 6.21 May 11, 2022: Sygnature Discovery to deploy Iktos’s AI for drug design software Makya
    • 6.22 May 03, 2022: Zimmer Biomet Announces First Quarter 2022 Financial Results
    • 6.23 Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
    • 6.24 Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
    • 6.25 Mar 08, 2022: Straumann Holding announce Invitation of half-year financial results webcast
    • 6.26 Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
    • 6.27 Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
    • 6.28 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company’s director and board secretary
    • 6.29 Jan 21, 2022: Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7
    • 6.30 Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
    • 6.31 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • 6.32 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development 11

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Segment 12

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Territory 13

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Regulatory Path 14

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Estimated Approval Date 15

Dental Bone Graft Substitutes & Regenerative Materials – Ongoing Clinical Trials 16

Dental Bone Graft Substitutes & Regenerative Materials Companies – Pipeline Products by Stage of Development 17

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development 19

3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

PuraMatrix Bone Void Filler – Product Status 21

PuraMatrix Bone Void Filler – Product Description 22

Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Healiguide – Product Status 23

Healiguide – Product Description 23

Osseograft – Product Status 24

Osseograft – Product Description 24

Osseomold – Product Status 24

Osseomold – Product Description 25

Cayman Chemical Co Pipeline Products & Ongoing Clinical Trials Overview 26

KMN-159 Collagen Hydrogel Combination Device – Product Status 26

KMN-159 Collagen Hydrogel Combination Device – Product Description 26

CellSeed Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Cell Sheet – Periodontal Tissue Regeneration – Product Status 27

Cell Sheet – Periodontal Tissue Regeneration – Product Description 27

Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 28

Xenograft Implant – Dental – Product Status 28

Xenograft Implant – Dental – Product Description 28

credentis AG Pipeline Products & Ongoing Clinical Trials Overview 29

CUROLOX Perio – Product Status 29

CUROLOX Perio – Product Description 29

curasan AG Pipeline Products & Ongoing Clinical Trials Overview 30

Cerasorb Foam Dental – Product Status 30

Cerasorb Foam Dental – Product Description 30

Cerasorb Paste Dental – Product Status 31

Cerasorb Paste Dental – Product Description 31

curasan AG – Ongoing Clinical Trials Overview 32

Cerasorb Foam Dental – Retrospective, Mono-centric Post-market Clinical Follow-up Study on the Use of Cerasorb Foam for Socket Preservation in Dental Surgery 33

Fujifilm Corp Pipeline Products & Ongoing Clinical Trials Overview 34

FF-37101 – Product Status 34

FF-37101 – Product Description 34

Histocell SL Pipeline Products & Ongoing Clinical Trials Overview 35

HR018-Neofibrin – Product Status 35

HR018-Neofibrin – Product Description 35

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 36

Electrospun Scaffold – Product Status 36

Electrospun Scaffold – Product Description 36

Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Urist – Product Status 37

Urist – Product Description 37

Ivory Graft Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Ivory Dentin Graft – Product Status 38

Ivory Dentin Graft – Product Description 38

Ivory Graft Ltd – Ongoing Clinical Trials Overview 39

Ivory Dentin Graft – Safety and Efficacy Evaluation of the Ivory Dentin Graft Device – Long Term Follow-up 40

Malla Reddy Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 41

Bacno Gel – Product Status 41

Bacno Gel – Product Description 41

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 42

MaxiGuide – Product Status 42

MaxiGuide – Product Description 42

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 43

MD05-P – Product Status 43

MD05-P – Product Description 43

MD08 – Product Status 44

MD08 – Product Description 44

Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview 45

Bone Inductive Implant – Product Status 45

Bone Inductive Implant – Product Description 45

Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 46

OrthoNovaOss – Product Status 46

OrthoNovaOss – Product Description 46

Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Striate+ – Product Status 47

Striate+ – Product Description 47

Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 48

DentoGen-CR – Product Status 48

DentoGen-CR – Product Description 48

Orthogen LLC – Ongoing Clinical Trials Overview 49

DentoGen-CR – Evaluation of the Effectiveness of Using Calcium Sulfate Bone Graft in the Context of Immediate Grafting Around Dental Implants 50

Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

GCT-101 – Product Status 51

GCT-101 – Product Description 51

Orthosera GmbH Pipeline Products & Ongoing Clinical Trials Overview 52

Antibiotic Bone Graft – Product Status 52

Antibiotic Bone Graft – Product Description 52

PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

D-PLEX500 – Product Status 53

D-PLEX500 – Product Description 53

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 54

Inorganic Dental Cement – Product Status 54

Inorganic Dental Cement – Product Description 54

RevBio Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Tetranite – Dental Bone Graft – Product Status 55

Tetranite – Dental Bone Graft – Product Description 55

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 56

BioCaS – Product Status 56

BioCaS – Product Description 56

Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 57

Enhanced Bone Graft – Product Status 57

Enhanced Bone Graft – Product Description 57

Next Generation Biomaterials – Product Status 58

Next Generation Biomaterials – Product Description 58

Soft Tissue Control Implant – Product Status 58

Soft Tissue Control Implant – Product Description 58

SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

DentaColl – Product Status 59

DentaColl – Product Description 59

SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

SweetBio GTR (Guided Tissue Regeneration) Membrane – Product Status 60

SweetBio GTR (Guided Tissue Regeneration) Membrane – Product Description 60

Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Tetramax – Product Status 61

Tetramax – Product Description 61

Tetratherix Pty Ltd – Ongoing Clinical Trials Overview 62

Tetramax – PET-B: Post Extraction Use of TetraMax Part B (TMB).. A Comparator Controlled Clinical Investigation Comparing the Bone Healing Capability of the Investigational Product “TetraMax Plus BioOss” and the Gold Standard Standard of Care Comparator “BioOssCollagen” (BioOssCol), for Adults Who Have Been Treatment Planned for Tooth Extraction/s and Implant Placement at the Same Extraction Site/s 63

Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 64

Tigran Porous Titanium Granules – Alveolar Fillings – Product Status 64

Tigran Porous Titanium Granules – Alveolar Fillings – Product Description 64

University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview 65

Collagen – Bone Regeneration – Product Status 65

Collagen – Bone Regeneration – Product Description 65

University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 66

Piezoelectric Mesh – Product Status 66

Piezoelectric Mesh – Product Description 66

University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 67

Injectable Scaffold – Product Status 67

Injectable Scaffold – Product Description 67

ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 68

ZetaDent – Product Status 68

ZetaDent – Product Description 68

Glossary 103

Figures

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development 11

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Segment 12

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Territory 13

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Regulatory Path 14

Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Estimated Approval Date 15

Dental Bone Graft Substitutes & Regenerative Materials – Ongoing Clinical Trials 16

Frequently asked questions

Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.